Anastomosis Devices Market

The global market value of the anastomosis devices market was estimated to be USD 3.5 billion in 2023 and is projected to grow at a CAGR of 8.3% during the forecast period. Increasing incidence of targeted diseases and growth in the number of surgical procedures are driving demand in the market. Increasing demand for minimally invasive procedures during surgery is driving demand in the market significantly.

The rising prevalence of cardiovascular and gastrointestinal diseases is fueling the growth in the market. Increasing cases of coronary artery diseases, colorectal cancer, and inflammatory bowel diseases are spurring the market growth. Surgeons prefer automated anastomosis devices for their efficiency and reduced operative time, particularly in laparoscopic and robotic-assisted surgeries. Widespread use of cutting-edge medical technologies is driving growth in the market.

Growth Drivers

Innovations such as bioabsorbable anastomotic devices and robotic-assisted anastomosis are enhancing precision and outcomes. Older adults are more prone to conditions like cardiovascular diseases, and gastrointestinal diseases are promoting the growth in anastomosis devices. Rising healthcare expenditure and hospital investments are driving the market towards significant success. Better reimbursement policies in many a region are fueling the market growth. Innovations around minimally invasive surgical techniques bolster patient outcomes and streamline operational efficiencies, resulting in shorter recovery times and reduced postoperative complications.

Countries with advanced healthcare infrastructure and affordable surgical costs are witnessing higher surgical volumes, further propelling the market growth significantly. The growing focus on patient outcome and healthcare expenditure strengthens the market dynamics.

Segmentation

By Product

·         Surgical Staplers

o   Manual Surgical Staplers

o   Powered Surgical Staplers

·         Surgical Sutures

o   Absorbable Sutures

o   Synthetic Sutures

o   Polyglactin 910 Sutures

o   Poliglecaprone 25 Sutures

o   Polydioxanone Sutures

o   Polyglycolic Acid Sutures

o   Other Synthetic Sutures

o   Natural Sutures

o   Non-Absorbable Sutures

o   Polypropylene Sutures

o   Nylon Sutures

o   Stainless Steel Sutures

o   Other Non-Absorbable Sutures

o   Automated Suturing Devices

o   Disposable Automated Suturing Devices

o   Reusable Automated Suturing Devices

·         Surgical Sealants and Adhesives

o   Biological Surgical Sealants and Adhesives

o   Fibrin-Based Sealants & Adhesives

o   Collagen-Based Sealants and Adhesives

o   Albumin-Based Sealants and Adhesives

o   Synthetic and Semisynthetic Sealants and Adhesives

o   PEG Hydrogel-Based Sealants and Adhesives

o   Cyanoacrylate-Based Sealants and Adhesives

o   Urethane-Based Sealants and Adhesives

o   Other Synthetic and Semisynthetic Sealants and Adhesives

By Application

·         Cardiovascular & Thoracic Surgery

·         Gastrointestinal Surgery

·         Orthopedic Surgery

·         Gynecological Surgery

·         Other Applications

By End User

·         Hospitals

·         Ambulatory Surgery Centers

·         Other End Users

By Region

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

The Anastomosis Devices Market by Application Segmentation

On the basis of the applications, the anastomosis devices market is segmented into cardiovascular and thoracic surgery, gastrointestinal surgery, orthopedic surgery, gynecological surgeries, and other applications. The increasing number of cardiac arrest cases due to lifestyle imbalance is the reason behind the dominance of the cardiovascular and thoracic surgery segment.

Increasing incidence of coronary artery diseases and other cardiovascular conditions necessitates the bypass grafting procedures, which rely on the anastomosis devices market. Minimally invasive coronary artery bypass grafting procedures are gaining traction. Reduced surgical complications, unlike the traditional suturing techniques in cardiovascular surgeries, are driving the demand in the market.

Anastomosis devices improve efficiency, reduce anastomotic leaks, and lower post-surgical complications, making them the preferred choice in high-risk procedures. High adoption of thoracic surgeries like lung transplants, esophagostomies, and other thoracic surgeries also require precise vascular and gastrointestinal anastomosis, boosting market growth in this segment.

Regional Outlook

On the basis of the regions, the anastomosis devices market is segmented into 5 regions: Asia-Pacific, North America, Latin America, the Middle East and Africa, and Europe. North America is currently the leading market due to advanced healthcare infrastructure and a high prevalence of cardiovascular diseases and gastrointestinal diseases.

The United States of America has witnessed the high prevalence of coronary artery diseases and colorectal cancer, driving demand for the anastomosis devices market. Presence of major medical companies like Medtronic, Ethicon, and Intuitive Surgical that continuously invest in technological advancements. Insurance and government support for surgical procedures make adoption easier.

Asia-Pacific is expected to grow the fastest due to rising healthcare expenditure in countries like China, India, and Japan. Increasing surgical procedures due to a growing elderly population and prevalence of chronic diseases. Expanding medical tourism in countries like India and Thailand, boosting the demand for cost-effective surgical devices. Technological advancements in the region are also playing a pivotal role in market growth. Surgeons in the region are gradually shifting towards staplers, suturing devices, and automated anastomosis systems for faster recovery and reduced complications.

Rising prevalence of gastrointestinal diseases along with cardiovascular diseases, with countries like China and India experiencing a surge in coronary artery bypass grafting procedures. Increasing cases of colorectal cancer and gastrointestinal surgeries also contribute to higher demand for the anastomosis device market. Countries like Japan, South Korea, and China have rapidly growing populations, leading to a higher incidence of diseases requiring surgical interventions.

Governments are heavily investing in modernizing hospitals and surgical facilities. The rise of medical tourism in countries like India, Thailand, and Malaysia boosts demand for advanced surgical devices. Rising adoption of minimally invasive procedures and the presence of key market players and local manufacturing are driving growth in the region. Initiatives like Made in China 2025 and India’s medical device sector growth policies encourage domestic production and innovation.

Europe is also expected to dominate during the forecast period. The region's well-established healthcare systems, particularly in countries such as Germany, France, and the United Kingdom, support the widespread use of cutting-edge medical technologies. These nations collectively hold a large share of the European market due to their robust medical infrastructure and the presence of key industry players. The adoption of minimally invasive procedures, such as laparoscopic and robotic-assisted surgeries, has also accelerated market growth, as these techniques rely heavily on advanced anastomosis devices like surgical staplers, sutures, and sealants to improve patient outcomes and reduce recovery times.

Key Players

·         Johnson & Johnson

·         Medtronic Plc

·         B. Braun Melsungen

·         Intuitive Surgical Inc.

·         Artivion Inc.

·         MIZUHO Corporation

·         Getinge

·         Peters Surgical

·         Baxter

·         Medical Device Business Services, Inc.

·         CarpoNovum AB

·         Vascular Graft Solutions Ltd.

·         Medline Industries, LP.

·         Seger Surgical Solutions Ltd.

·         Other Players